4//SEC Filing
Drexler Ryan Charles 4
Accession 0001493152-20-022769
CIK 0001415684other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:00 PM ET
Size
5.7 KB
Accession
0001493152-20-022769
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Drexler Ryan Charles
Director10% Owner
Transactions
- Other
Convertible Promissory Note
2020-11-29$0.23/shExercise: $0.23Exp: 2021-07-01→ Common Stock (12,486,813 underlying)
Footnotes (1)
- [F1]On November 29, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,871,967 with the Company (the "November 2020 Convertible Note"). Mr. Drexler may elect to convert all or any portion of the convertible amount into shares of the Company's common stock at any time for $0.23 per share at any time. Both the principal and any accrued but unpaid interest under the November 2020 Convertible Note will become due and payable on July 1, 2021, unless earlier converted or repaid.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeother
Related Parties
1- filerCIK 0001648033
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 5:00 PM ET
- Size
- 5.7 KB